RecruitingPersistent Atrial Fibrillation
Endocardial Mapping With the CoreMap EP Mapping System
Eligible age
18–80 yrs
Accepts
All genders
Locations
3 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a global, multi-site, prospective, feasibility study.
Sponsor: CoreMap Inc.
You may qualify if…
- ✓ 1. Subject has persistent or long-standing persistent AF, at the discretion of the investigator (Phase 1 \& 2)
- ✓ 2. Subject has PerAF with no history of prior AF ablation therapy (Phase 3)
- ✓ 3. Subject is 18 to 80 years of age
- ✓ 4. Subject has presence of AF-related symptoms and is scheduled for clinically indicated standard of care AF ablation to manage PerAF (Phase 2 or 3) or long-standing PerAF (Phase 2)
- ✓ 5. Subject is able to provide written informed consent
- ✓ 6. Subject is able and willing to complete all study procedures
You may not qualify if…
- ✕ 1. Any of the following within three months of enrollment:
- ✕ 1. Myocardial infarction (MI)
- ✕ 2. Any surgical or percutaneous cardiac procedure including coronary intervention and cardiac ablation
- ✕ 3. Confirmed thrombus on imaging
- ✕ 2. Any of the following within six months of enrollment:
- ✕ 1. Cardiac surgery including coronary artery bypass grafting, ventriculotomy, atriotomy
- ✕ 2. Thromboembolic event (stroke)
- ✕ 3. Any of the following cardiac conditions:
Where it's recruiting
Source: ClinicalTrials.gov · NCT06529978 · last updated 2026-07-14